Filing Flows › Medpace Holdings (MEDP) › Guidance history
Medpace Holdings (MEDP) guidance history: what it guided and what it reported
Medpace Holdings gave guidance in 12 earnings releases on file since Feb 12, 2024. Of 6 guided periods since reported, it met or beat its own guidance 6 times (100%). Revenue: 2 of 2, on average +0.5% against the guided midpoint. Its releases raised guidance once and lowered it once.
Revenue
Met or beat 2 of 2 periods (0 above, 2 within, 0 below).
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $2.8B–$2.9B (Feb 9, 2026) → reaffirmed $2.8B–$2.9B (Apr 22, 2026) → raised $2.8B–$2.9B (Jul 22, 2026) → reaffirmed $2.8B–$2.9B (Oct 21, 2026) | — | to be reported | — |
| FY2025 | $2.1B–$2.2B (Feb 10, 2025) → raised $2.1B–$2.2B (Apr 21, 2025) → raised $2.4B–$2.5B (Jul 21, 2025) → raised $2.5B–$2.5B (Oct 22, 2025) | $2.5B | within the range | +1.0% |
| FY2024 | $2.1B–$2.2B (Feb 12, 2024) → reaffirmed $2.1B–$2.2B (Apr 22, 2024) → lowered $2.1B–$2.2B (Jul 22, 2024) → lowered $2.1B–$2.1B (Oct 21, 2024) | $2.1B | within the range | 0.0% |
GAAP net income
Met or beat 2 of 2 periods (2 above, 0 within, 0 below).
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $487M–$511M (Feb 9, 2026) → reaffirmed $487M–$511M (Apr 22, 2026) → raised $494M–$514M (Jul 22, 2026) → raised $514M–$524M (Oct 21, 2026) | — | to be reported | — |
| FY2025 | $378M–$402M (Feb 10, 2025) → reaffirmed $378M–$402M (Apr 21, 2025) → raised $405M–$428M (Jul 21, 2025) → raised $431M–$439M (Oct 22, 2025) | $451M | above the range | +3.7% |
| FY2024 | $326M–$348M (Feb 12, 2024) → raised $347M–$369M (Apr 22, 2024) → raised $361M–$383M (Jul 22, 2024) → raised $376M–$388M (Oct 21, 2024) | $404M | above the range | +5.9% |
Tax rate
Met or beat 2 of 2 periods (0 above, 0 within, 2 below).
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | 18.5%–19.5% (Feb 9, 2026) → raised 19.0%–20.0% (Apr 22, 2026) → lowered 19.0%–19.5% (Jul 22, 2026) → reaffirmed 19.0%–19.5% (Oct 21, 2026) | — | to be reported | — |
| FY2025 | 18.0%–19.0% (Feb 10, 2025) → lowered 15.5%–16.5% (Apr 21, 2025) → raised 18.5%–19.0% (Jul 21, 2025) → lowered 18.2%–18.8% (Oct 22, 2025) | 16.8% | below the range | -1.7 pts |
| FY2024 | 16.0%–17.0% (Feb 12, 2024) → lowered 15.0%–16.0% (Apr 22, 2024) → reaffirmed 15.0%–16.0% (Jul 22, 2024) → raised 15.5%–16.5% (Oct 21, 2024) | 15.0% | below the range | -1.0 pts |
GAAP EPS
This line is not in the statements Filing Flows reads, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $16.68–$17.50 (Feb 9, 2026) → reaffirmed $16.68–$17.50 (Apr 22, 2026) → raised $17.25–$17.95 (Jul 22, 2026) → raised $17.97–$18.32 (Oct 21, 2026) | — | to be reported | — |
| FY2025 | $11.93–$12.69 (Feb 10, 2025) → raised $12.26–$13.04 (Apr 21, 2025) → raised $13.76–$14.53 (Jul 21, 2025) → raised $14.60–$14.86 (Oct 22, 2025) | — | — | — |
| FY2024 | $10.18–$10.87 (Feb 12, 2024) → raised $10.79–$11.47 (Apr 22, 2024) → raised $11.24–$11.93 (Jul 22, 2024) → raised $11.71–$12.09 (Oct 21, 2024) | — | — | — |
Adjusted EBITDA
The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $605M (Feb 9, 2026) → reaffirmed $605M (Apr 22, 2026) → raised $618M (Jul 22, 2026) → raised $638M (Oct 21, 2026) | — | to be reported | — |
| FY2025 | $462M (Feb 10, 2025) → reaffirmed $462M (Apr 21, 2025) → raised $515M (Jul 21, 2025) → raised $545M (Oct 22, 2025) | — | — | — |
| FY2024 | $400M (Feb 12, 2024) → raised $415M (Apr 22, 2024) → raised $430M (Jul 22, 2024) → raised $450M (Oct 21, 2024) | — | — | — |
The latest quarter
Medpace Holdings, Q3 2026: revenue $716M (+8% year over year), operating margin 23.1%, net earnings $137M, operating cash flow $217M. The chart follows the revenue to costs, profit and cash.
Questions
Does Medpace Holdings beat its guidance?
Medpace Holdings gave guidance in 12 earnings releases on file since Feb 12, 2024. Of 6 guided periods since reported, it met or beat its own guidance 6 times (100%). Revenue: 2 of 2, on average +0.5% against the guided midpoint.
How often does Medpace Holdings raise guidance?
Its earnings releases raised guidance once and lowered it once since Feb 12, 2024.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.